Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy
Background Oncolytic virotherapy (OV) is an immunotherapy that incorporates viral cancer cell lysis with engagement of the recruited immune response against cancer cells. Pediatric solid tumors are challenging targets because they contain both an inert immune environment and a quiet antigenic landsc...
Saved in:
| Main Authors: | Chun-Yu Chen, Mohammed G Ghonime, Uksha Saini, Michael C Kelly, Justin C Roth, Pin-Yi Wang, Katherine Miller, Ilse Hernandez-Aguirre, Yeaseul Kim, Xiaokui Mo, Joseph R Stanek, Tim Cripe, Elaine Mardis, Kevin A Cassady |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/9/10/e002939.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oncolytic HSV-IL27 expression improves CD8 T cell function and therapeutic activity in syngeneic glioma models
by: Alexia K Martin, et al.
Published: (2025-07-01) -
Oncolytic herpes simplex virus reprograms cancer-associated fibroblasts to enhance antitumor immunity in pancreatic cancer
by: Feilong Zhou, et al.
Published: (2025-09-01) -
An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma
by: Joseph W. Jackson, et al.
Published: (2025-09-01) -
4-1BBL-Armed Oncolytic Herpes Simplex Virus Exerts Antitumor Effects in Pancreatic Ductal Adenocarcinoma
by: Wenrui Gao, et al.
Published: (2024-11-01) -
Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors
by: Selene Ingusci, et al.
Published: (2024-03-01)